Siemens Healthineers Thailand
Siemens Healthineers Thailand is the Thai subsidiary of Siemens Healthineers AG. ~10% of Thai medical-device market value. Portfolio: CT, MRI, ultrasound, molecular imaging, cath lab, IVD (clinical chemistry, immunoassay, blood gas, Atellica, Aptio lab automation). Private subsidiary; consolidated into parent group.
Snapshot
Headline numbers a buyer checks first.
Thai market share
~10% by value
FY2024
Parent
Siemens Healthineers AG (ETR: SHL)
Subsidiary
Portfolio
Imaging, IVD, cath lab
FY2024
Status
Private Thai subsidiary
Ongoing
What this subsidiary actually does
Siemens Healthineers Thailand imports, installs, and services imaging, diagnostic equipment for Thai public, private hospitals, diagnostic centres. CT, MRI leadership across major Thai hospital systems (BDMS, Bumrungrad, private, public). Ultrasound, mammography portfolio. IVD lab-automation (Atellica, Aptio) serves large private-lab, hospital-lab customers.[]
Competitive position: leader in high-end imaging, IVD automation; competes with GE HealthCare, Philips in imaging, Abbott, Roche Diagnostics in IVD. Medical tourism, private-hospital capex cycle, UCS public-hospital equipment procurement drive revenue. Post-2018 spinoff from Siemens parent established dedicated operating focus.[, ]
Business segments
Imaging
CT, MRI, molecular imaging, cath lab
SOMATOM CT, MAGNETOM MRI, Symbia SPECT/CT, and Artis cath-lab systems. Thai private and public hospitals account for approximately 60% of imaging revenue; medical tourism hospitals are the premium tier.
IVD and lab automation
Atellica and Aptio lab platforms
Atellica Solution (clinical chemistry, immunoassay) and Aptio Automation serve large hospital labs and independent diagnostics chains. IVD is estimated at 25–30% of Thai revenues, with recurring reagent contracts.
Ultrasound and point-of-care
ACUSON ultrasound — cardiology and radiology
ACUSON ultrasound platform covers cardiology, radiology, OB-GYN. Point-of-care ultrasound (POCUS) is a growth segment in Thai emergency medicine and rural hospital outreach programmes.
Digital and AI
AI-Rad Companion and syngo
AI-powered diagnostic tools (AI-Rad Companion) and syngo.via reading workflow are deployed at premium Thai hospitals. Digital health services are a small but fast-growing revenue line.
Thai medical imaging and IVD — peer comparison
Estimated Thai market share and portfolio focus by vendor (FY2024).
Parent ticker
ABT (NYSE)
Est. Thai share
~7% IVD
Core strength
Point-of-care IVD, immunoassay
Roche Diagnostics Thailand
| Vendor | Parent ticker | Est. Thai share | Core strength |
|---|---|---|---|
| Siemens Healthineers Thailand | SHL (ETR) | ~10% | CT, MRI, IVD automation |
| GE HealthCare Thailand | GEHC (NASDAQ) | ~12% | Ultrasound, MRI, monitoring |
| Philips Thailand | PHIA (AMS) | ~8% | Interventional X-ray, monitoring |
| Abbott Thailand | ABT (NYSE) | ~7% IVD | Point-of-care IVD, immunoassay |
| Roche Diagnostics Thailand | ROG (SIX) | ~8% IVD | Clinical chemistry, molecular diagnostics |
Watchpoints 2025–2026
Hospital capex cycle
BDMS, Bumrungrad imaging refresh
BDMS and Bumrungrad International plan $0.29–20B combined capex in 2025–2027. Imaging equipment refresh is a material component. Siemens Healthineers is positioned for CT, MRI replacement contracts.
Public tender
MoPH CT and MRI procurement
Universal Coverage Scheme equipment budget allocations drive public-hospital CT, MRI tenders. Thai FDA regulatory alignment and government-pricing frameworks affect bid economics.
IVD lab consolidation
Atellica platform wins
Thai diagnostic lab consolidation (Synphaet, BDMS Central Lab, and independent chains) creates large-volume automation tender opportunities. Reagent lock-in on Atellica platforms provides 7–10 year revenue visibility.
Related Market profiles
Peers, parents, partners, agencies, and other Medical Devices actors.
Competitor
GE HealthCare Thailand
Direct imaging, monitoring competitor.
Open Market profile →
Competitor
Philips Thailand
Direct imaging competitor.
Open Market profile →
Competitor
Abbott Thailand
IVD competitor.
Open Market profile →
Sector peer
Becton Dickinson Thailand (BD Thailand)
Thai subsidiary of Becton Dickinson (NYSE: BDX); distributes and markets BD's medical devices, diagnostics, and life-science products across the Thai healthcare market.
Open Market profile →
Sources + data provenance
Every filing, filing-adjacent register, or trusted industry source cited in this profile.
Siemens Healthineers Thailand — Subsidiary Disclosures
Medical Tourism Thailand — MoPH, TAT Statistics
| Source | Publisher | Grade | As of |
|---|---|---|---|
| Siemens Healthineers Thailand — Subsidiary Disclosures | Siemens Healthineers Thailand | Supporting | 2025-12-31 |
| Medical Tourism Thailand — MoPH, TAT Statistics | Ministry of Public Health, Tourism Authority of Thailand | Primary | 2026-03-31 |
Reports featuring this profile
Related Market profiles
competitor
GE HealthCare Thailand
US-parent MNC imaging, ultrasound, monitoring leader; 2023 GE spinoff; ~8% Thai market share.
competitor
Philips Thailand
Dutch-parent MNC imaging, patient monitoring, respiratory; ~8% Thai market share; post-2021 CPAP recall reputational overhang.
competitor
Abbott Thailand
US-parent MNC diagnostics, CGM, nutrition, cardiovascular; FreeStyle Libre anchor; ~6% Thai medical-device market share.